振东制药(300158.SZ)拟3000万元参与设立基金投资于生物医药领域

Core Viewpoint - Zhendong Pharmaceutical (300158.SZ) has signed a partnership agreement with several investment institutions to enhance its strategic development and competitiveness in the biopharmaceutical sector while managing investment risks effectively [1] Group 1: Partnership Agreement - The company has entered into a partnership agreement with Hainan Longmen Private Fund Management Partnership, Wen Nuo Yao, Beijing New Medical Consulting Co., Ltd., and Shanghai Vino Run Cheng Pharmaceutical Technology Co., Ltd. [1] - The partnership aims to leverage the strengths and resources of professional investment institutions to achieve long-term investment returns [1] Group 2: Investment Details - Zhendong Pharmaceutical will act as a limited partner, committing a capital contribution of 30 million RMB, which represents a 28.5687% stake in the partnership [1] - The investment will primarily focus on the biopharmaceutical field [1]